Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Reeve BB"" wg kryterium: Autor


Tytuł:
Validating a Self-Reported Medication Nonadherence Measure in the Context of Multiple Chronic Diseases and Routes of Medication Administration Among Patients with Type 2 Diabetes
Autorzy:
Voils CI
Gavin KL
Thorpe CT
Pabich SK
Reeve BB
Mian GJ
Faacks A
Kronish IM
Pokaż więcej
Temat:
diabetes
medication adherence
cognitive interview
Medicine (General)
R5-920
Źródło:
Patient Preference and Adherence, Vol Volume 16, Pp 3119-3130 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/validating-a-self-reported-medication-nonadherence-measure-in-the-cont-peer-reviewed-fulltext-article-PPA; https://doaj.org/toc/1177-889X
Dostęp URL:
https://doaj.org/article/b425b2ad412049ab80f9e67824a5f29d  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Developing a discrete choice experiment in Malawi: eliciting preferences for breast cancer early detection services
Autorzy:
Kohler RE
Lee CN
Gopal S
Reeve BB
Weiner BJ
Wheeler SB
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
Patient Preference and Adherence, Vol 2015, Iss default, Pp 1459-1472 (2015)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/developing-a-discrete-choice-experiment-in-malawi-eliciting-preference-peer-reviewed-article-PPA; https://doaj.org/toc/1177-889X
Dostęp URL:
https://doaj.org/article/0b39d33bbb344604839357fcb6510c63  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans
Autorzy:
Weidenbacher HJ
Beadles CA
Maciejewski ML
Reeve BB
Voils CI
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
Patient Preference and Adherence, Vol 2015, Iss default, Pp 327-336 (2015)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/extent-and-reasons-for-nonadherence-to-antihypertensive-cholesterol-an-peer-reviewed-article-PPA; https://doaj.org/toc/1177-889X
Dostęp URL:
https://doaj.org/article/c6a54b0643624751a990f37886340488  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions
Autorzy:
Voils CI
King HA
Neelon B
Hoyle RH
Reeve BB
Maciejewski ML
Yancy WS Jr
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
Patient Preference and Adherence, Vol 2014, Iss default, Pp 643-650 (2014)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/characterizing-weekly-self-reported-antihypertensive-medication-nonadh-a16719; https://doaj.org/toc/1177-889X
Dostęp URL:
https://doaj.org/article/f2e008f7a5ed496b88b6716f889dc6ba  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer
Autorzy:
Zullig LL
Carpenter WR
Provenzale DT
Weinberger M
Reeve BB
Williams CD
Jackson GL
Pokaż więcej
Temat:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
Cancer Management and Research, Vol 2013, Iss default, Pp 157-163 (2013)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/the-association-of-race-with-timeliness-of-care-and-survival-among-vet-a13780; https://doaj.org/toc/1179-1322
Dostęp URL:
https://doaj.org/article/79e3e5686d7c4d3d9430b08f2b567ece  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Autorzy:
Maringwa JT
Quinten C
King M
Ringash J
Osoba D
Coens C
Martinelli F
Vercauteren J
Cleeland CS
Flechtner H
Gotay C
Greimel E
Taphoorn MJ
Reeve BB
Koch JS
Weis J
Smit EF
van Meerbeeck JP
Bottomley A
EORTC PROBE project and the Lung Cancer Group
Pokaż więcej
Źródło:
Supportive Care in Cancer; Nov2011, Vol. 19 Issue 11, p1753-1760, 8p
Czasopismo naukowe
Tytuł:
Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®).
Autorzy:
Flynn KE
Jeffery DD
Keefe FJ
Porter LS
Shelby RA
Fawzy MR
Gosselin TK
Reeve BB
Weinfurt KP
Flynn, Kathryn E
Jeffery, Diana D
Keefe, Francis J
Porter, Laura S
Shelby, Rebecca A
Fawzy, Maria R
Gosselin, Tracy K
Reeve, Bryce B
Weinfurt, Kevin P
Pokaż więcej
Źródło:
Psycho-Oncology; Apr2011, Vol. 20 Issue 4, p378-386, 9p
Czasopismo naukowe
Tytuł:
Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)).
Autorzy:
Flynn KE
Shelby RA
Mitchell SA
Fawzy MR
Hardy NC
Husain AM
Keefe FJ
Krystal AD
Porter LS
Reeve BB
Weinfurt KP
Flynn, Kathryn E
Shelby, Rebecca A
Mitchell, Sandra A
Fawzy, Maria R
Hardy, N Chantelle
Husain, Aatif M
Keefe, Francis J
Krystal, Andrew D
Porter, Laura S
Pokaż więcej
Źródło:
Psycho-Oncology; Oct2010, Vol. 19 Issue 10, p1086-1093, 8p
Czasopismo naukowe
Tytuł:
Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology.
Autorzy:
Jeffery DD
Tzeng JP
Keefe FJ
Porter LS
Hahn EA
Flynn KE
Reeve BB
Weinfurt KP
Jeffery, Diana D
Tzeng, Janice P
Keefe, Francis J
Porter, Laura S
Hahn, Elizabeth A
Flynn, Kathryn E
Reeve, Bryce B
Weinfurt, Kevin P
Pokaż więcej
Źródło:
Cancer (0008543X); 3/15/2009, Vol. 115 Issue 6, p1142-1153, 12p
Czasopismo naukowe
Tytuł:
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.
Autorzy:
Barsevick AM (AUTHOR)
Cleeland CS (AUTHOR)
Manning DC (AUTHOR)
O'Mara AM (AUTHOR)
Reeve BB (AUTHOR)
Scott JA (AUTHOR)
Sloan JA (AUTHOR)
Barsevick, Andrea M (AUTHOR)
Cleeland, Charles S (AUTHOR)
Manning, Donald C (AUTHOR)
O'Mara, Ann M (AUTHOR)
Reeve, Bryce B (AUTHOR)
Scott, Jane A (AUTHOR)
Sloan, Jeff A (AUTHOR)
ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes) (CORPORATE AUTHOR)
Pokaż więcej
Źródło:
Journal of Pain & Symptom Management. Jun2010, Vol. 39 Issue 6, p1086-1099. 14p.
Czasopismo naukowe
Tytuł:
Protocol for the development of a Core Outcome Set (COS) for Adolescents and Young Adults (AYAs) with cancer.
Autorzy:
Husson O; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Janssen SHM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Durham, NC, USA.
Sodergren SC; School of Health Sciences, University of Southampton, Southampton, UK.
Cheung CK; School of Social Work, University of Maryland, Baltimore, MD, USA.
McCabe MG; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.
Salsman JM; Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC, USA.
van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Darlington AS; School of Health Sciences, University of Southampton, Southampton, UK. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 24; Vol. 24 (1), pp. 126. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Health Facilities*
Neoplasms*/diagnosis
Neoplasms*/therapy
Humans ; Adolescent ; Young Adult ; Data Collection ; Vulnerable Populations
Czasopismo naukowe
Tytuł:
Did a bot eat your homework? An assessment of the potential impact of bad actors in online administration of preference surveys.
Autorzy:
Gonzalez JM; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
Grover K; Icahn School of Medicine, Mount Sinai, New York, New York, United States of America.
Leblanc TW; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina, United States of America.
Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 05; Vol. 18 (10), pp. e0287766. Date of Electronic Publication: 2023 Oct 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Choice Behavior*
Patient Preference*
Surveys and Questionnaires ; Probability
Czasopismo naukowe
Tytuł:
Patient-reported quality of life in adolescents and young adults with cancer who received radiation therapy.
Autorzy:
Corrigan KL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Reeve BB; Department of Population Health Sciences, Department of Pediatrics, Center for Health Measurement, Duke University School of Medicine, Durham, North Carolina, USA.
Salsman JM; Department of Social Sciences and Health Policy, Wake Forest University, Winston-Salem, North Carolina, USA.
Siembida EJ; Institution of Health System Science, Northwell Health, Manhasset, New York, USA.
Smith GL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Swartz MC; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lee KL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Afridi F; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Andring LM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Peterson SK; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (13), pp. 14157-14170. Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Quality of Life*
Sarcoma*
Humans ; Adolescent ; Young Adult ; Adult ; Surveys and Questionnaires ; Mental Health ; Patient Reported Outcome Measures
Czasopismo naukowe
Tytuł:
Identifying symptomatic adverse events using the patient-reported outcomes version of the common terminology criteria for adverse events in patients with non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
Autorzy:
Zhu Y; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA.
Jean-Baptiste M; Evidera Inc., Bethesda, Maryland, USA.
Lenderking WR; Evidera Inc., Bethesda, Maryland, USA.; Evidera Inc., Waltham, Massachusetts, USA.
Bell JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA.
Revicki DA; Evidera Inc., Bethesda, Maryland, USA.
Lin HM; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA.
Brake R; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA.
Reeve BB; Duke University School of Medicine, Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 5494-5505. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Neoplasms*/drug therapy
Humans ; ErbB Receptors/genetics ; Mutagenesis, Insertional ; Patient Reported Outcome Measures
Czasopismo naukowe
Tytuł:
Investigating gender-based differential item functioning on the Kansas City Cardiomyopathy Questionnaire (KCCQ) using qualitative content analysis.
Autorzy:
Coles TM; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA. .; Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA. .
Lucas N; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
McFatrich M; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
Henke D; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
Ridgeway JL; Mayo Clinic, Rochester, NY, USA.
Behnken EM; Mayo Clinic, Rochester, NY, USA.
Weinfurt K; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
Reeve BB; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
Corneli A; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
Dunlay SM; Mayo Clinic, Rochester, NY, USA.
Spertus JA; Saint Luke's Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA.
Lin L; Department of Population Health Sciences, Center for Health Measurement, Duke University, Durham, NC, USA.
Piña IL; Wayne State University, Detroit, Michigan, USA.; Central Michigan University, Mount Pleasant, Michigan, USA.; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Bocell FD; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Tarver ME; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Dohse H; Tour de Heart, Hailey, ID, USA.
Saha A; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Caldwell B; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Mar; Vol. 32 (3), pp. 841-852. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure*/therapy
Cardiomyopathies*
Male ; Adult ; Humans ; Female ; Aged ; Quality of Life/psychology ; Health Status ; Stroke Volume ; Kansas ; Ventricular Function, Left ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive study.
Autorzy:
Dombeck C; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.
Swezey T; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.
Gonzalez Sepulveda JM; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Clinical Research Institute, Duke University School of Medicine, NC, Durham, USA.
Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.; Duke Clinical Research Institute, Duke University School of Medicine, NC, Durham, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
LeBlanc TW; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
Chandler D; Amgen, Inc, Thousand Oaks, CA, USA.
Corneli A; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA. .; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. .; Duke Clinical Research Institute, Duke University School of Medicine, NC, Durham, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 19; Vol. 23 (1), pp. 65. Date of Electronic Publication: 2023 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*/drug therapy
Humans ; Female ; Male ; Quality of Life ; Qualitative Research
Czasopismo naukowe
Tytuł:
Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian Cancer.
Autorzy:
Akinyemiju T; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Joshi A; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.
Deveaux A; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.
Wilson LE; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.
Chen D; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.
Meernik C; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.
Bevel M; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.
Gathings J; ETR Services, Durham, NC 27705, USA.
Fish L; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Barrett N; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Worthy V; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Boyce X; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Martin K; ETR Services, Durham, NC 27705, USA.
Robinson C; ETR Services, Durham, NC 27705, USA.
Pisu M; Division of Preventive Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Liang M; Division of Preventive Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Potosky A; Cancer Prevention and Control Program Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.
Huang B; Kentucky Cancer Registry, University of Kentucky, Lexington, KY 40506, USA.
Ward K; Georgia Cancer Registry, Emory University, Atlanta, GA 30322, USA.
Schymura MJ; New York State Cancer Registry, New York State Department of Health, Albany, NY 12203, USA.
Berchuck A; Division of Gynecologic Oncology, Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27708, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Dec 19; Vol. 14 (24). Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
Autorzy:
Evon DM; Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Dong M; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
Peter J; Division of Gastroenterology, Hepatology & Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Michael L; Center for Gastroenterology Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Lok AS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Nelson DR; Division of Gastroenterology, Hepatology & Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Stewart PW; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Sep; Vol. 29 (9), pp. 795-806. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Amides ; Antiviral Agents/therapeutic use ; Benzimidazoles ; Benzofurans ; Carbamates ; Cyclopropanes ; Drug Therapy, Combination ; Fatigue ; Female ; Fluorenes/therapeutic use ; Genotype ; Hepacivirus ; Humans ; Imidazoles ; Male ; Middle Aged ; Nausea/drug therapy ; Quinoxalines ; Sofosbuvir/therapeutic use ; Sulfonamides
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies